Company News
Cohance Lifesciences Invests USD 18M in ADC Strategy
Cohance Lifesciences announces USD 18 million investment in NJ Bio and Aruka Bio to advance its Antibody-drug Conjugate strategy.
Investment includes USD 13M to increase NJ Bio stake to 67.3% and USD
